当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Haume Shalde
This study aimed to assess the impact of intrinsic and extrinsic factors on the pharmacokinetics of esomeprazole, comparing its intravenous (IV) and oral administration routes. Esomeprazole, a proton pump inhibitor widely used for acid-related disorders, exhibits variable pharmacokinetic profiles due to individual variability and external factors. A randomized crossover design was employed, involving healthy participants receiving both IV and oral esomeprazole under different conditions. Blood samples were collected at predetermined intervals, and plasma concentrations were analyzed using advanced chromatographic methods. The results indicated that intrinsic factors such as age, gender, and genetic variations minimally affected esomeprazole pharmacokinetics, regardless of administration route. Similarly, extrinsic factors like diet, concomitant medications, and smoking showed consistent effects on both IV and oral administration. This suggests that the pharmacokinetic behavior of esomeprazole remains relatively consistent across administration routes and is robust against various factors. These findings contribute to a better understanding of esomeprazole's pharmacokinetic profile, supporting its clinical utility in diverse patient populations. Further research could explore specific mechanisms underlying these observations and their clinical implications.